News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Maimon Yossi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/23/2023 |
4
| Maimon Yossi (CFO, Secretary and Treasurer) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 69,872 shares
@ $0
Disposed/sold 70,500 options to buy
@ $5.16, valued at
$363.8k
Disposed/sold 9,460 options to buy
@ $6.5, valued at
$61.5k
Disposed/sold 19,170 options to buy
@ $11.26, valued at
$215.9k
Disposed/sold 31,950 options to buy
@ $9.105, valued at
$290.9k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Maimon Yossi (CFO, Secretary & Treasurer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 31,950 options
@ $9.105, valued at
$290.9k
|
|
| 01/06/2021 |
4
| Maimon Yossi (CFO, Secretary & Treasurer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 8,520 shares
@ $0
Granted 19,170 options
@ $11.26, valued at
$215.9k
|
|
| 05/11/2020 |
4
| Maimon Yossi (CFO, Secretary & Treasurer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 11,352 shares
@ $0 |
|
| 05/07/2020 |
3
| Maimon Yossi (CFO) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 09/14/2018 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 700,000 options to buy
@ $0.56, valued at
$392k
|
|
| 12/15/2015 |
4
| Maimon Yossi (Vice President & CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.78, valued at
$7.8k
|
|
| 05/07/2015 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.72, valued at
$430k
|
|
| 07/18/2012 |
4
| Maimon Yossi (Vice President & CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Granted 185,000 shares
@ $0 |
|
| 05/04/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/08/2010 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc.|
Txns:
| Sold 70,000 shares
@ $9.67, valued at
$676.9k
Exercised 77,769 shares
@ $0.972, valued at
$75.6k
Paid exercise price by delivering 7,769 shares
@ $9.73, valued at
$75.6k
Exercised 77,769 options to buy
@ $0.972, valued at
$75.6k
|
|
| 09/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/19/2009 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
| 07/08/2009 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
| 05/19/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 03/13/2009 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
| 02/27/2009 |
4
| Maimon Yossi (VP, CFO) has filed a Form 4 on Protalix BioTherapeutics, Inc. |
|
|